Radiopharmaceuticals market was valued at US$ 6.8 billion in 2024 and is projected to hit the market valuation of US$ 13.4 billion by 2033 at a CAGR of 7.8% during the forecast period 2025–2033.
Hospital supplies market size was valued at US$ 43.99 billion in 2024 and is projected to hit the market valuation of US$ 125.56 billion by 2033 at a CAGR of 12.36% during the forecast period 2025–2033.
Artificial insemination market was valued at US$ 2.8 billion in 2024 and is projected to hit the market valuation of US$ 5.5 billion by 2033 at a CAGR of 7.9% during the forecast period 2025–2033.
Intraoral scanners market was valued at US$ 786.5 million in 2024 and is projected to hit the market valuation of US$ 1,794.8 million by 2033 at a CAGR of 9.6% during the forecast period 2025–2033.
Blood clot retrieval devices market was valued at US$ 1.68 billion in 2024 and is projected to hit the market valuation of US$ 5.68 billion by 2033 at a CAGR of 14.5% during the forecast period 2025–2033.
Nanocellulose market size was pegged at US$ 709.7 million in 2024 and is projected to hit the market valuation of US$ 4,213.9 million by 2033 at a CAGR of 21.9% during the forecast period 2025–2033.
Stem cell manufacturing market was valued at US$24.26 billion in 2024 and is projected to hit the market valuation of US$ 65.49 billion by 2033 at a CAGR of 11.96% during the forecast period 2025–2033.
Benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is projected to hit the market valuation of US$ 16.5 billion by 2033 at a CAGR of 5.1% during the forecast period 2025–2033.